Lindemulder E - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies.

Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S. Swanson J, et al. Among authors: lindemulder e. Arch Gen Psychiatry. 2003 Feb;60(2):204-11. doi: 10.1001/archpsyc.60.2.204. Arch Gen Psychiatry. 2003. PMID: 12578439 Clinical Trial.

Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications.

Modi NB, Lam A, Lindemulder E, Wang B, Gupta SK. Modi NB, et al. Among authors: lindemulder e. Biopharm Drug Dispos. 2000 Nov;21(8):321-6. doi: 10.1002/bdd.248. Biopharm Drug Dispos. 2000. PMID: 11514951

Modeling of circadian testosterone in healthy men and hypogonadal men.

Gupta SK, Lindemulder EA, Sathyan G. Gupta SK, et al. Among authors: lindemulder ea. J Clin Pharmacol. 2000 Jul;40(7):731-8. doi: 10.1177/00912700022009486. J Clin Pharmacol. 2000. PMID: 10883414 Clinical Trial.

Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.

Gupta SK, Sathyan G, Lindemulder EA, Ho PL, Sheiner LB, Aarons L. Gupta SK, et al. Among authors: lindemulder ea. Clin Pharmacol Ther. 1999 Jun;65(6):672-84. doi: 10.1016/S0009-9236(99)90089-9. Clin Pharmacol Ther. 1999. PMID: 10391673 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters